Legal Action

Published on October 22nd, 2018


Sarah Cannon Cancer Center Database

A investigation revealed that numerous cancer centers in the U.S. are deceptively using patient testimonials in their marketing materials, that is, testimonials that promote anecdotal, atypical patient results without clearly and conspicuously disclosing what the generally expected results for a patient in a similar situation would be. Moreover, within this sampling of deceptive testimonials many also promote clinical trials (i.e., research endeavors with no guarantee of therapeutic benefit), as well as novel treatments, such as immunotherapy and/or experimental procedures, without clearly and conspicuously disclosing their limitations, risks and relative rarity.

Below is a sampling of’s findings for Sarah Cannon Cancer Center.  If any of the testimonials attribute the patient’s success to a clinical trial, the entry appears in bold italics.

This center was notified of’s findings on October 22nd, 2018.

To learn more about the statistics and criteria used in’s investigation, as well as other information, click here.

Name Cancer Type Testimonial SEER 5-Year Survival Rate*
Amanda Breast, Stage 4 Website 27.0%
Brad Esophageal, Stage 2 Website 23.6%
Carol Breast, Stage 4 Website 27.0%
Charles Lung Website 18.6%
Erin Melanoma, Stage 4 Video (as seen on Youtube) 22.5%
John Melanoma, Stage 4 Website 22.5%
Judy Breast, Stage 4 Video (as seen on Youtube) 27.0%
Karin Acute Myeloid Leukemia (AML) Video (as seen on Youtube) 27.4%
Paul Lung, Stage 4 Website 1 4.7%
Paul Lung, Stage 4 Facebook 4.7%


Print Friendly, PDF & Email


Leave a Reply

Back to Top ↑